Analysts: Nike to See Growth Internationally and 4 New Opinions Investors Must Read Now

MAKO Surgical Corp. (NASDAQ:MAKO): Piper Jaffray attributes yesterday’s pullback in the company’s shares to commentary from surgeons and industry contacts at the AAOS annual meeting about Blue Belt Technology, which is a smaller but well known competitor in robotic surgery for orthopaedics. According to Piper, the concerns are unwarranted, and the firm recommends using the pullback in shares as a buying opportunity. The firm reiterates an Overweight rating on the stock with a $23 price target.